Today's pre-market stock movers: WMT, AMZN, KO, BABA and more

$Liberty Energy (LBRT.US)$ +11.6%, $F5 Inc (FFIV.US)$ +6.9%, $Encore Wire (WIRE.US)$ + 5.6%, $Archer Daniels Midland (ADM.US)$ +5.5%, $Bank of N.T Butterfield & Son (NTB.US)$ +5%, $Albany International (AIN.US)$ +5%, $3M (MMM.US)$ +4.0%,

$Shell Midstream (SHLX.US)$ +10% (Shell USA to acquire all units in SHLX held by public at $15.85/unit total value $1.96 bln)

$BridgeBio Pharma (BBIO.US)$ +6.9% (BridgeBio Pharma Announces Positive Interim Results from a Phase 2 Trial of Infigratinib in Achondroplasia Demonstrating an Increase in Annualized Height Velocity of 1.52 cm/year in Children 5 Years of Age and Older and Adds 5th Cohort to Trial)

$GE Aerospace (GE.US)$ +4.3% (surprised Wall Street with higher quarterly profit and positive cash flow as recovery in the aviation industry drove up its jet engine business)

$MyMD Pharmaceuticals (MYMD.US)$ +3.8% (further advancement of its fully funded Phase 2 clinical trial of lead drug candidate MYMD-1 as a therapy for delaying aging and expanding healthy lifespan)

$Ionis Pharmaceuticals (IONS.US)$ +2.3% (FDA accepts NDA and grants Priority Review of tofersen for rare form of ALS)

$Seagen (SGEN.US)$ +2% (Seagen and Astellas Announce Positive Topline Results For PADCEV (enfortumab vedotin-ejfv) with KEYTRUDA (pembrolizumab) as First-Li ne Treatment for Advanced Urothelial Cancer)

$iRhythm Technologies (IRTC.US)$ +1.3% (names new CFO)

$Aarons Holdings Co Inc (AAN.US)$ -19%, $PetMed Express (PETS.US)$ -7.9%, $Shutterstock (SSTK.US)$ -6.9%, $Hexcel (HXL.US)$ -6.3%, $Allegiant Travel (ALGT.US)$ -4%, $Corning (GLW.US)$ -3.9%, $TransUnion (TRU.US)$ -3.1%, $Watsco (WSO.US)$ -2.9%, $NXP Semiconductors (NXPI.US)$ -2%

$Vinco Ventures (BBIG.US)$ -17.5% (Vinco Ventures Thwarts What it Believes was a Hostile Takeover Attempt by the Farnsworth Group)

$UBS Group (UBS.US)$ -7.6% (Posted net profit attributable to shareholders of $2.108 billion, below analyst expectations aggregated by the Swiss bank)

$Kohl's Corp (KSS.US)$ -5.4% (In sympathy with WMT lowering guidance)

$Waldencast (WALD.US)$ -5.4% (Waldencast Acquisition Corp, shareholders approve business combination with Obagi Skincare and Milk Makeup)

$Target (TGT.US)$ -5.2% (In sympathy with WMT lowering guidance)

$Legend Biotech (LEGN.US)$ -5% (stock offering)

$TJX Companies (TJX.US)$ -4.9% (In sympathy with WMT lowering guidance)

$Macy's (M.US)$ -4.7% (In sympathy with WMT lowering guidance)

$Dollar General (DG.US)$ -4.3% (In sympathy with WMT lowering guidance)

$Dollar Tree (DLTR.US)$ -3.8% (In sympathy with WMT lowering guidance)

$Humacyte (HUMA.US)$ -2.6% (Humacyte Preclinical Data on Small-Diameter Human Acellular Vessel in Coronary Artery Bypass Grafting Presented at American Heart Association Meeting)

$Verve Therapeutics (VERV.US)$ -2.5% (closes upsized 9.58 mln offering)

$General Motors (GM.US)$ -1.9% (reported second-quarter earnings that missed Wall Street's estimates, after supply chain issues led it to ship fewer vehicles than expected)